Literature DB >> 30563406

TRIM11 cooperates with HSF1 to suppress the anti-tumor effect of proteotoxic stress drugs.

Liang Chen1,2, Xiaolu Yang2.   

Abstract

Cells mainly rely on stress proteins, such as heat-shock proteins (HSPs), to respond to various proteotoxic conditions. These proteins protect tumor cells and enhance their survive. However, the regulation of stress proteins involved in protein quality control (PQC) is still poorly understood. Here, we report that the expression of TRIM11, an important regulator of PQC, is positively correlated with tumor cell surviaval during the proteotoxic conditions induced by anti-tumor drugs. In addition, HSF1 is required for TRIM11-mediated removal of protein aggregates and resistance of proteotoxic stress. During these processes, TRIM11 interacts with and stabilizes HSF1, increaseing HSF1 levels in the nucleus. These findings identify that TRIM11, through cooperation with HSF1, protects cells against the proteotoxic stress and promotes tumor cell survival.

Entities:  

Keywords:  HSF1; Proteotoxic stress; TRIM11; anti-tumor; cell viability

Mesh:

Substances:

Year:  2018        PMID: 30563406      PMCID: PMC6343683          DOI: 10.1080/15384101.2018.1558870

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  34 in total

Review 1.  Mammalian heat shock protein families. Expression and functions.

Authors:  C Burel; V Mezger; M Pinto; M Rallu; S Trigon; M Morange
Journal:  Experientia       Date:  1992-07-15

Review 2.  Proteostasis impairment in protein-misfolding and -aggregation diseases.

Authors:  Mark S Hipp; Sae-Hun Park; F Ulrich Hartl
Journal:  Trends Cell Biol       Date:  2014-06-16       Impact factor: 20.808

Review 3.  HSF1: Guardian of Proteostasis in Cancer.

Authors:  Chengkai Dai; Stephen Byers Sampson
Journal:  Trends Cell Biol       Date:  2015-11-18       Impact factor: 20.808

4.  TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.

Authors:  K Di; M E Linskey; D A Bota
Journal:  Oncogene       Date:  2012-11-26       Impact factor: 9.867

5.  A cellular system that degrades misfolded proteins and protects against neurodegeneration.

Authors:  Lili Guo; Benoit I Giasson; Alex Glavis-Bloom; Michael D Brewer; James Shorter; Aaron D Gitler; Xiaolu Yang
Journal:  Mol Cell       Date:  2014-05-29       Impact factor: 17.970

Review 6.  The role of bortezomib in the treatment of lymphoma.

Authors:  Paul Barr; Richard Fisher; Jonathan Friedberg
Journal:  Cancer Invest       Date:  2007-12       Impact factor: 2.176

Review 7.  Adapting proteostasis for disease intervention.

Authors:  William E Balch; Richard I Morimoto; Andrew Dillin; Jeffery W Kelly
Journal:  Science       Date:  2008-02-15       Impact factor: 63.714

8.  TRIM24 links a non-canonical histone signature to breast cancer.

Authors:  Wen-Wei Tsai; Zhanxin Wang; Teresa T Yiu; Kadir C Akdemir; Weiya Xia; Stefan Winter; Cheng-Yu Tsai; Xiaobing Shi; Dirk Schwarzer; William Plunkett; Bruce Aronow; Or Gozani; Wolfgang Fischle; Mien-Chie Hung; Dinshaw J Patel; Michelle Craig Barton
Journal:  Nature       Date:  2010-12-16       Impact factor: 49.962

9.  HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers.

Authors:  Marc L Mendillo; Sandro Santagata; Martina Koeva; George W Bell; Rong Hu; Rulla M Tamimi; Ernest Fraenkel; Tan A Ince; Luke Whitesell; Susan Lindquist
Journal:  Cell       Date:  2012-08-03       Impact factor: 41.582

10.  Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis.

Authors:  Chengkai Dai; Luke Whitesell; Arlin B Rogers; Susan Lindquist
Journal:  Cell       Date:  2007-09-21       Impact factor: 41.582

View more
  2 in total

1.  TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway.

Authors:  Yanfeng Liu; Shishi Tao; Lijuan Liao; Yang Li; Hongchang Li; Zhihuan Li; Lilong Lin; Xiaochun Wan; Xiaolu Yang; Liang Chen
Journal:  Nat Commun       Date:  2020-01-17       Impact factor: 14.919

2.  SOX13/TRIM11/YAP axis promotes the proliferation, migration and chemoresistance of anaplastic thyroid cancer.

Authors:  Jianing Tang; Zelin Tian; Xing Liao; Gaosong Wu
Journal:  Int J Biol Sci       Date:  2021-01-01       Impact factor: 6.580

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.